Literature DB >> 31642869

Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults.

Donald Clark1, Lisandro D Colantonio2, Yuan-I Min1, Michael E Hall1, Hong Zhao2, Robert J Mentz3, Daichi Shimbo4, Gbenga Ogedegbe5, George Howard6, Emily B Levitan2, Daniel W Jones1, Adolfo Correa1, Paul Muntner2.   

Abstract

Importance: The prevalence of hypertension and the risk for hypertension-related cardiovascular disease (CVD) are high among black adults. The population-attributable risk (PAR) accounts for both prevalence and excess risk of disease associated with a risk factor. Objective: To examine the PAR for CVD associated with hypertension among black adults. Design, Setting, and Participants: This prospective cohort study used data on 12 497 black participants older than 21 years without CVD at baseline who were enrolled in the Jackson Heart Study (JHS) from September 26, 2000, through March 31, 2004, and cardiovascular events were adjudicated through December 31, 2015. The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study participants were enrolled from July 1, 2003, through September 12, 2007, and cardiovascular events were adjudicated through March 31, 2016. Data analysis was performed from March 26, 2018, through July 10, 2019. Exposures: Normal blood pressure and hypertension were defined using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds. Main Outcomes and Measures: The PAR for CVD associated with hypertension, calculated using multivariable-adjusted hazard ratios (HRs) for CVD, coronary heart disease, heart failure, and stroke associated with hypertension vs normal blood pressure. Prevalence of hypertension among non-Hispanic black US adults 21 years and older without CVD was calculated using data from the National Health and Nutrition Examination Survey, 2011-2014.
Results: Of 12 497 participants, 1935 had normal blood pressure (638 [33.0%] male; mean [SD] age, 53.5 [12.4] years), 929 had elevated blood pressure (382 [41.1%] male; mean [SD] age, 58.6 [11.8] years), and 9633 had hypertension (3492 [36.3%] male; mean [SD] age, 62.0 [10.3] years). For a maximum 14.3 years of follow-up, 1235 JHS and REGARDS study participants (9.9%) experienced a CVD event. The multivariable-adjusted HR associated with hypertension was 1.91 (95% CI, 1.48-2.46) for CVD, 2.41 (95% CI, 1.59-3.66) for coronary heart disease, 1.52 (95% CI, 1.01-2.30) for heart failure, and 2.20 (95% CI, 1.44-3.36) for stroke. The prevalence of hypertension was 53.2% among non-Hispanic black individuals. The PAR associated with hypertension was 32.5% (95% CI, 20.5%-43.6%) for CVD, 42.7% (95% CI, 24.0%-58.4%) for coronary heart disease, 21.6% (95% CI, 0.6%-40.8%) for heart failure, and 38.9% (95% CI, 19.4%-55.6%) for stroke. The PAR was higher among those younger than 60 years (54.6% [95% CI, 37.2%-68.7%]) compared with those 60 years or older (32.0% [95% CI, 11.9%-48.1%]). No differences were present in subgroup analyses. Conclusions and Relevance: These findings suggest that a substantial proportion of CVD cases among black individuals are associated with hypertension. Interventions to maintain normal blood pressure throughout the life course may reduce the incidence of CVD in this population.

Entities:  

Mesh:

Year:  2019        PMID: 31642869      PMCID: PMC6813577          DOI: 10.1001/jamacardio.2019.3773

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  31 in total

Review 1.  Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment?

Authors:  Daniel W Jones; Friedrich C Luft; Paul K Whelton; Michael H Alderman; John E Hall; Eric D Peterson; Robert M Califf; David A McCarron
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

Review 2.  Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.

Authors:  Donald M Lloyd-Jones; Yuling Hong; Darwin Labarthe; Dariush Mozaffarian; Lawrence J Appel; Linda Van Horn; Kurt Greenlund; Stephen Daniels; Graham Nichol; Gordon F Tomaselli; Donna K Arnett; Gregg C Fonarow; P Michael Ho; Michael S Lauer; Frederick A Masoudi; Rose Marie Robertson; Véronique Roger; Lee H Schwamm; Paul Sorlie; Clyde W Yancy; Wayne D Rosamond
Journal:  Circulation       Date:  2010-01-20       Impact factor: 29.690

3.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

4.  The National Physical Activity Plan: a call to action from the American Heart Association: a science advisory from the American Heart Association.

Authors:  William E Kraus; Vera Bittner; Lawrence Appel; Steven N Blair; Timothy Church; Jean-Pierre Després; Barry A Franklin; Todd D Miller; Russell R Pate; Ruth E Taylor-Piliae; Dorothea K Vafiadis; Laurie Whitsel
Journal:  Circulation       Date:  2015-04-27       Impact factor: 29.690

5.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

6.  Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

7.  Racial differences in the impact of elevated systolic blood pressure on stroke risk.

Authors:  George Howard; Daniel T Lackland; Dawn O Kleindorfer; Brett M Kissela; Claudia S Moy; Suzanne E Judd; Monika M Safford; Mary Cushman; Stephen P Glasser; Virginia J Howard
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

8.  Association of race and sex with risk of incident acute coronary heart disease events.

Authors:  Monika M Safford; Todd M Brown; Paul M Muntner; Raegan W Durant; Stephen Glasser; Jewell H Halanych; James M Shikany; Ronald J Prineas; Tandaw Samdarshi; Vera A Bittner; Cora E Lewis; Christopher Gamboa; Mary Cushman; Virginia Howard; George Howard
Journal:  JAMA       Date:  2012-11-07       Impact factor: 56.272

Review 9.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

10.  Quantifying Importance of Major Risk Factors for Coronary Heart Disease.

Authors:  Michael J Pencina; Ann Marie Navar; Daniel Wojdyla; Robert J Sanchez; Irfan Khan; Joseph Elassal; Ralph B D'Agostino; Eric D Peterson; Allan D Sniderman
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

View more
  14 in total

1.  Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018.

Authors:  Paul Muntner; Shakia T Hardy; Lawrence J Fine; Byron C Jaeger; Gregory Wozniak; Emily B Levitan; Lisandro D Colantonio
Journal:  JAMA       Date:  2020-09-22       Impact factor: 56.272

2.  Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS).

Authors:  Mohammad Saatchi; Mohammad Ali Mansournia; Davood Khalili; Rajabali Daroudi; Kamran Yazdani
Journal:  Risk Manag Healthc Policy       Date:  2020-08-05

3.  Risk-Based Intensive Blood Pressure Lowering and Prevention of Heart Failure: A SPRINT Post Hoc Analysis.

Authors:  Rebecca J Molsberry; Leah Rethy; Michael C Wang; Rupal C Mehta; Donald M Lloyd-Jones; Hongyan Ning; Cora E Lewis; Clyde W Yancy; Sanjiv J Shah; Sadiya S Khan
Journal:  Hypertension       Date:  2021-11-01       Impact factor: 10.190

4.  Factors Associated With Not Having a Healthcare Visit in the Past Year Among US Adults With Hypertension: Data From NHANES 2013-2018.

Authors:  Oluwasegun P Akinyelure; Demetria Hubbard; Swati Sakhuja; Shakia T Hardy; Suzanne Oparil; Andrea L Cherrington; Kristi Reynolds; Gregory Wozniak; Paul Muntner
Journal:  Am J Hypertens       Date:  2022-02-01       Impact factor: 3.080

5.  Apparent Treatment-Resistant Hypertension Among Stroke Survivors: A Transcontinental Study Assessing Impact of Race and Geography.

Authors:  Fred Stephen Sarfo; Esther Olasoji; Grant P Banfill; Bruce Ovbiagele; Alexis N Simpkins
Journal:  Am J Hypertens       Date:  2022-08-01       Impact factor: 3.080

6.  It's Time for a Haircut: a Perspective on Barbershop Health Interventions Serving Black Men.

Authors:  Kelsey B Bryant; C Adair Blyler; Robert E Fullilove
Journal:  J Gen Intern Med       Date:  2020-03-16       Impact factor: 5.128

7.  Race- and Sex-Specific Population Attributable Fractions of Incident Heart Failure: A Population-Based Cohort Study From the Lifetime Risk Pooling Project.

Authors:  Arjun Sinha; Hongyan Ning; Mercedes R Carnethon; Norrina B Allen; John T Wilkins; Donald M Lloyd-Jones; Sadiya S Khan
Journal:  Circ Heart Fail       Date:  2021-03-25       Impact factor: 8.790

8.  Association of Cumulative Systolic Blood Pressure With Long-Term Risk of Cardiovascular Disease and Healthy Longevity: Findings From the Lifetime Risk Pooling Project Cohorts.

Authors:  Orna Reges; Hongyan Ning; John T Wilkins; Colin O Wu; Xin Tian; Michael J Domanski; Donald M Lloyd-Jones; Norrina B Allen
Journal:  Hypertension       Date:  2020-12-21       Impact factor: 10.190

9.  Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.

Authors:  Kelsey B Bryant; Andrew E Moran; Dhruv S Kazi; Yiyi Zhang; Joanne Penko; Natalia Ruiz-Negrón; Pamela Coxson; Ciantel A Blyler; Kathleen Lynch; Laura P Cohen; Gabriel S Tajeu; Valy Fontil; Norma B Moy; Joseph E Ebinger; Florian Rader; Kirsten Bibbins-Domingo; Brandon K Bellows
Journal:  Circulation       Date:  2021-04-15       Impact factor: 39.918

10.  Hypertension control in sub-Saharan Africa: Clinical inertia is another elephant in the room.

Authors:  Eva L van der Linden; Charles Agyemang; Bert-Jan H van den Born
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-05-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.